Andrea Mattarei Selected Research

Kv1.3 Potassium Channel

4/2022	Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma.
1/2017	Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Mattarei Research Topics

Disease

12	Neoplasms (Cancer) 05/2022 - 01/2017
2	Adenocarcinoma 05/2022 - 01/2017
2	Tetanus 11/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2020
1	Multiple Myeloma 04/2022
1	Leukemia 02/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022
1	Autoimmune Hepatitis 01/2022
1	Disease Progression 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Muscle Spasticity (Spastic) 11/2021
1	Bites and Stings (Sting) 01/2020
1	Snake Bites (Snake Bite) 01/2020
1	Paralysis (Palsy) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Pathologic Processes 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Obesity 07/2017
1	Insulin Resistance 07/2017
1	Glioma (Gliomas) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Botulism 12/2015

Drug/Important Bio-Agent (IBA)

5	Potassium Channels (Potassium Channel)IBA 05/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 05/2022 - 05/2018
3	Liposomes (Liposome)IBA 01/2021 - 05/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2017
2	Kv1.3 Potassium ChannelIBA 04/2022 - 01/2017
2	Glycerol (Glycerine)FDA LinkGeneric 01/2021 - 07/2017
1	Albumin-Bound Paclitaxel FDA Link 05/2022
1	Gemcitabine FDA Link 05/2022
1	venetoclaxIBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Nucleic AcidsIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	AvidinIBA 01/2022
1	ExotoxinsIBA 11/2021
1	tetanospasmin (tentoxilysin)IBA 11/2021
1	Formaldehyde (Formol)FDA Link 11/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	flopropioneIBA 01/2021
1	taipoxinIBA 01/2020
1	VenomsIBA 01/2020
1	NUCC-390IBA 01/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2020
1	PorinsIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	LigandsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Voltage-Dependent Anion ChannelsIBA 01/2019
1	CateninsIBA 01/2019
1	Arginine (L-Arginine)FDA Link 05/2018
1	Furocoumarins (Furanocoumarins)IBA 01/2018
1	QuercetinIBA 10/2017
1	Ion Channels (Ion Channel)IBA 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	CarbamatesIBA 07/2017
1	pterostilbeneIBA 07/2017
1	AdipokinesIBA 07/2017
1	NeurotoxinsIBA 01/2017
1	5-(4-phenylbutoxy)psoralenIBA 01/2017
1	Clofazimine (Lamprene)FDA Link 01/2017
1	incobotulinumtoxinA FDA Link 12/2015

Therapy/Procedure

3	Therapeutics 04/2022 - 11/2021